Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects
Juliet McColm; Claire Brittain; Subha Suriyapperuma; Steven Swanson; Sitra Tauscher‐Wisniewski; Joanne Foster; Danny Soon; Kimberley Jackson
Author Information: Eli Lilly and Company
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.